Page 10 - Clinical Connections - Autumn 2024

ºÚÁÏÉç

 

 

 

 

 

Page 10 - Clinical Connections - Autumn 2024
P. 10

ºÚÁÏÉç RESEARCH    STUDY    VETERINARY SERVICES       ºÚÁÏÉç.AC.UK
          Equine
          ADVANCES IN SARCOID TREATMENT


          Andy Fiske-Jackson, Deputy Head of ºÚÁÏÉç Equine and Associate Professor in Equine Surgery
         R      VC  Equine  has  long  been  at  the   Tumour specific electroporation
                            furthering
                        of
                forefront
                                      equine
                                              Since the end of 2022 we have also been
                oncology,  with  the  use  of  novel
          chemotherapeutic drugs and multi-modal   able to offer TSE treatment. This modality
                                              compared to others is especially useful for
          treatment regimes. This includes a range of   the treatment of large tumours and sarcoids
          treatment modalities for sarcoids, tailored to   situated over vital structures, such as joints,
          the specific needs of individual patients.   large  blood  vessels  or  the  parotid  region.
            Modalities we use for treating sarcoids   Surgical resection and topical cytotoxic
          at ºÚÁÏÉç’s Equine Referral Hospital include   creams carry a large risk of damage to
          electrochemotherapy (ECT), tumour specific   these vital structures.
          electroporation  (TSE)  and  thermofield
          treatment.
            We  have  been  offering  ECT  to  treat
          sarcoids since 2017. ºÚÁÏÉç Equine was the
          first veterinary centre in the UK to offer that
          treatment  option.  This  treatment  involves
          injecting carboplatin, followed by application
          of a small electric current across the sarcoid.
            The  procedure  can  be  combined  with
          other sarcoid treatments, such as laser   Performing TSE                Injecting bleomycin
          excision. ECT is especially valuable for
          sarcoids in areas where cytotoxic cream   The cytotoxic drugs available for use in   Initially we hoped only a single  TSE
          cannot be safely applied, such as around   horses work by preventing cell division.   treatment would be required but, as with
          the eye, or where the cream could be   However,  the  uptake  of  these  drugs  into   ECT, repeat treatments appear to be more
          rubbed onto unaffected areas.       the cell is very limited due to the intact   effective.
            Three ECT treatments are usually   membrane of the target cancer cell. Applying
          required, all under a brief general   an electric current to the cell causes pores   Thermofield treatment
          anaesthetic or standing sedation, if the   to open in the cell membrane, allowing the   Currently  TSE  and  ECT  are  our  most
          treated area can be desensitised with nerve   drug to enter the cell.   utilised sarcoid treatments but we also offer
          blocks. Larger sarcoids may require surgical   Bleomycin, the drug we use with  TSE,   thermofield  treatment.  Application  of  heat
          debulking beforehand.               is increased in its concentration in the cell   (hyperthermia)  achieves  a  similar  effect
            ECT has been shown to be quick,   by several hundred-fold or more following   as  ECT  but  also  offers  several  additional
          safe  and  efficacious  but  other  treatment   application of an electric current.  This   advantages. Heat not only increases uptake
          modalities are more appropriate for certain   process is called electroporation.  This   of  drugs  and  potentiates  their  effects  but
          sarcoids.                           concept had already been adopted by ECT   also activates the patient’s immune system
                                              machines.                          and directly damages tumour cells by
                                               We have enjoyed good success with   suppressing new vessel growth and killing
                                              treating small shallow sarcoids in horses   cancer stem-like cells.
                                              with  ECT  but  static  ECT  can  cause   It  also  has  analgesic  properties,
                                              unwanted thermal necrosis and destruction   increasing patient comfort. In contrast
                                              of normal tissue.  TSE is an innovative   to  ECT,  thermofield  treatments  can  be
                                              dynamic  electroporation,  designed  to   performed without general anaesthesia.
                                              avoid such unwanted destruction of the
                                              surrounding normal tissue by constantly   The electrochemotherapy equipment
                                              measuring the conductivity of the tissue and   was funded by the ºÚÁÏÉç’s charity the
                                              adjusting the pulse train accordingly.  TSE   Animal Care Trust (ACT). The tumour
                                              also stimulates the host immune system to   specific electroporation equipment was
                                              attack the tumour or sarcoid.      purchased by funds donated to the ACT
                                               Like  all  machines  and  technologies,  we   by the Alice Noakes Memorial Charitable
                                              are continuing to learn how to optimise the   Trust.  The  thermofield  equipment  was
                                              use of TSE. We have found the procedure   purchased by funds donated to the ACT
                                              does require a general anaesthetic unless   by EBM Charitable Trust.
                                              we can desensitise the area to perform the
                                              treatment under sedation, such as on the
           Performing ECT                     lower limb.
                                                                                        For equine referrals, please call: 01707
                                                                                       666297
                                                                                        Email:
                                                                                       equinehospital@rvc.ac.uk
          10   Autumn 2024
   5   6   7   8   9   10   11   12